Clinical Trial

Role of FGF21 in Breast Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The present study aims to evaluate the serum level of FGF-21 in patients with breast cancer and its correlation with clinical, laboratory, and pathological data.
Trial Details
NCT Number NCT07113418
Lead Sponsor Assiut University
Conditions Breast Cancer
Enrollment 84 participants
Start Date 2025-09
Primary Completion 2026-09 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-08